Related Experiment Video
Updated: Mar 26, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
This review covers major clinical trials for common headache disorders, focusing on new therapies and formulations. It summarizes key therapeutic trials ongoing in 2015 from ClinicalTrials.gov and corporate data.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Annual review of clinical trials in headache disorders.
- Focus on multicenter trials for new and existing therapies.
Observation:
- Data compiled from ClinicalTrials.gov and corporate sources.
- Summary of major therapeutic headache trials ongoing as of end-2015.
Findings:
- Overview of recently completed and ongoing clinical investigations.
- Highlights novel therapeutic agents and formulations for headache treatment.
Implications:
- Informs clinicians and researchers about the latest advancements in headache therapeutics.
- Provides insights into the pipeline of treatments for common headache disorders.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
FDA Approved Drugs: Changes to Approved Drugs